QURE
uniQure N.V.
uniQure N.V. (QURE) has 12 SEC Form 4 filings (40 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 7, 2026.
The most active filer is CEO, Managing Director Kapusta Matthew C with 5 filings. Insiders have net sold $17.3M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Matthew Kapusta
- Employees:221
- HQ:Amsterdam, NH, NL
- IPO:2014-02-05
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$17.3M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$2.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| CEO, Managing Director | Sale | 21,082 | $952K | Jul 7 | SEC ↗ | |
| Chief Medical Officer | Sale | 30,000 | $1.4M | Jul 2 | SEC ↗ | |
| Director | Sale | 21,167 | $983K | Jul 2 | SEC ↗ | |
| Chief Medical Officer | Sale | 1,434 | $67K | Jun 30 | SEC ↗ | |
| CEO, Managing Director | Sale | 6,696 | $335K | Jun 26 | SEC ↗ | |
| CEO, Managing Director | Sale | 28,716 | $1.4M | Jun 26 | SEC ↗ | |
Kapusta Matthew CFirst filing | CEO, Managing Director | Sale | 164,429 | $7.3M | Jun 22 | SEC ↗ |
Kapusta Matthew CFirst filing | CEO, Managing Director | Sale | 41,671 | $2.1M | Jun 22 | SEC ↗ |
| Director | Sale | 11,685 | $526K | Jun 22 | SEC ↗ | |
Kaye JackFirst filing | Director | Sale | 5,295 | $225K | Jun 22 | SEC ↗ |
Potts JeannetteFirst filing | Chief Legal Officer | Sale | 5,237 | $145K | Jun 17 | SEC ↗ |
Balachandran MadhavanFirst filing | Director | Sale | 10,000 | $279K | Jun 17 | SEC ↗ |
O'Keefe KylieFirst filing | Chief Customer & Strat Officer | Sale | 15,936 | $431K | Jun 12 | SEC ↗ |
Abi-Saab WalidFirst filing | Chief Medical Officer | Sale | 45,000 | $1.1M | May 12 | SEC ↗ |
Related companies
uniQure N.V. is in the Healthcare sector.